Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants
- 31 December 1980
- journal article
- review article
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 3 (4) , 407-432
- https://doi.org/10.1016/0147-9571(80)90017-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The antileukemic effect of systemic non-specific BCG-immunostimulation vs systemic specific immunostimulation with irradiated isogeneic leukemic cellsPublished by Elsevier ,1978
- INTRAPLEURAL B.C.G. IMMUNOSTIMULATION IN LUNG CANCERThe Lancet, 1977
- Effectiveness of murine leukemia chemotherapy according to the immune stateCancer Immunology, Immunotherapy, 1977
- Trial of BCG immunotherapy in the treatment of resectable squamous cell carcinoma of the bronchus (stages I and II)Cancer Immunology, Immunotherapy, 1976
- BCG in the immunotherapy of Hodgkin's disease and non-Hodgkin's lymphomasCancer Immunology, Immunotherapy, 1976
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.The Lancet, 1974
- Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemiaPublished by Elsevier ,1974
- Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activityNature, 1974
- Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.British Journal of Cancer, 1969
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969